Canada markets closed

eFFECTOR Therapeutics, Inc. (EFTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.2000+0.0400 (+1.85%)
At close: 04:00PM EDT
2.1981 -0.00 (-0.09%)
After hours: 05:21PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.35M
Enterprise Value 12.52M
Trailing P/E 0.84
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)13.38
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.38

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3-84.00%
S&P500 52-Week Change 322.38%
52 Week High 337.0000
52 Week Low 31.6000
50-Day Moving Average 38.6342
200-Day Moving Average 312.6817

Share Statistics

Avg Vol (3 month) 3391.03k
Avg Vol (10 day) 3156.36k
Shares Outstanding 54.7M
Implied Shares Outstanding 64.7M
Float 83.59M
% Held by Insiders 12.84%
% Held by Institutions 114.02%
Shares Short (Apr 15, 2024) 4244.03k
Short Ratio (Apr 15, 2024) 40.3
Short % of Float (Apr 15, 2024) 46.67%
Short % of Shares Outstanding (Apr 15, 2024) 46.62%
Shares Short (prior month Mar 15, 2024) 4318.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Jan 12, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-85.26%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -33.73M
Net Income Avi to Common (ttm)-35.81M
Diluted EPS (ttm)-16.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.37M
Total Cash Per Share (mrq)4.98
Total Debt (mrq)20.55M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.77
Book Value Per Share (mrq)-1.94

Cash Flow Statement

Operating Cash Flow (ttm)-29.55M
Levered Free Cash Flow (ttm)-17.73M